BioTradingArena – Benchmark for LLMs to predict biotech stock movements

Show HN: BioTradingArena – Benchmark for LLMs to predict biotech stock movements

BioTradingArena – Benchmark for LLMs to predict biotech stock movements operates in show hn launch.

Profile

Hi HN,My friend and I have been experimenting with using LLMs to reason about biotech stocks. Unlike many other sectors, Biotech trading is largely event-driven: FDA decisions, clinical trial readouts, safety updates, or changes in trial design can cause a stock to 3x in a single day (https://www.biotradingarena.com/cases/MDGL_2023-12-14_Resmet...).Interpreting these ‘catalysts,’ which comes in the form of a press release, usually requires analysts with previous expertise in biology or medicine. A catalyst that sounds “positive” can still lead to a selloff if, for example: the effect size is weaker than expected- results apply only to a narrow subgroup- endpoints don’t meaningfully de-risk l

Its activity falls under show hn launch; the profile below is assembled from public directory data.

Its current recorded stage is Show HN launch.

Website: www.biotradingarena.com/hn